First Report on the Latvian SARS-CoV-2 Isolate Genetic Diversity

Area of Science:

• Virology
• Genomics
• Epidemiology

Background:

• Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) emerged as a global health crisis in late 2019.
• The first case in Latvia was recorded in March 2020, prompting rapid public health responses.
• By September 2020, Latvia had documented over 1,400 COVID-19 cases.

Purpose of the Study:

• To analyze the genetic diversity of SARS-CoV-2 isolates within Latvia.
• To provide the first comprehensive report on Latvian SARS-CoV-2 genetic sequences.
• To contribute to the understanding of viral evolution during the initial pandemic phase.

Main Methods:

• Initiation of a viral sequencing campaign in March 2020.
• Collaboration with local testing laboratories for sample collection.
• Whole-genome sequencing of 133 SARS-CoV-2 isolates from the first wave.

Main Results:

• Successful sequencing of 133 Latvian SARS-CoV-2 isolates, representing approximately 9.1% of cases during the first wave.
• Generation of the first publicly available full-length SARS-CoV-2 genome sequences from the Baltics region.
• Initial insights into the genetic landscape of SARS-CoV-2 in Latvia.

Conclusions:

• The study provides foundational data on the genetic diversity of SARS-CoV-2 in Latvia.
• Sequencing efforts have established a basis for ongoing genomic surveillance of the virus.
• Understanding local viral genetics is crucial for effective pandemic response and control.